Advanced organ support (ADVOS) in the critically ill: first clinical experience in patients with multiple organ failure

Annals of Intensive Care
Valentin FuhrmannStefan Kluge

Abstract

Prevalence of multiple organ failure (MOF) in critically ill patients is increasing and associated mortality remains high. Extracorporeal organ support is a cornerstone in the management of MOF. We report data of an advanced hemodialysis system based on albumin dialysis (ADVOS multi device) that can regulate acid-base balance in addition to the established properties of renal replacement therapy and albumin dialysis systems in critically ill patients with MOF. 34 critically ill patients with MOF received 102 ADVOS treatment sessions in the Department of Intensive Care Medicine of the University Medical Center Hamburg-Eppendorf. Markers of metabolic detoxification and acid-base regulation were collected and blood gas analyses were performed. A subgroup analyses were performed in patients with severe acidemia (pH < 7.2). Median number of treatment sessions was 2 (range 1-9) per patient. Median duration of treatment was 17.5 (IQR 11-23) hours per session. Treatment with the ADVOS multi-albumin dialysis device caused a significant decrease in bilirubin levels, serum creatinine, BUN and ammonia levels. The relative elimination rate of bilirubin was concentration dependent. Furthermore, a significant improvement in blood pH, HCO3- an...Continue Reading

References

Dec 1, 1983·Canadian Journal of Physiology and Pharmacology·P A Stewart
Mar 6, 2003·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Lars E SchmidtFin Stolze Larsen
Jan 1, 1954·The Journal of Clinical Investigation·P J DORMANR F PITTS
Oct 26, 2005·Intensive Care Medicine·Damien du CheyronPierre Charbonneau
Nov 3, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tarek I HassaneinAndres T Blei
Jun 10, 2009·Intensive Care Medicine·Valentin FuhrmannChristian Madl
Oct 23, 2009·The New England Journal of Medicine·Rinaldo BellomoSteve Su
May 13, 2010·American Journal of Respiratory and Critical Care Medicine·Laurent BrochardUNKNOWN ATS/ERS/ESICM/SCCM/SRLF Ad Hoc Committee on Acute Renal Failure
Jul 17, 2010·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver
Sep 4, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Carlo BasileCarlo Lomonte
Feb 15, 2011·Critical Care Medicine·Jean-Louis VincentMark D Williams
Jun 8, 2011·Intensive Care Medicine·Valentin FuhrmannPeter Schenk
Jun 19, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Bernhard JägerValentin Fuhrmann
Jul 17, 2012·JAMA : the Journal of the American Medical Association·V Marco RanieriArthur S Slutsky
Aug 29, 2012·Seminars in Dialysis·Sunny ElootRaymond Vanholder
Dec 6, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Rafael BañaresUNKNOWN RELIEF study group
Mar 12, 2013·Gastroenterology·Richard MoreauUNKNOWN CANONIC Study Investigators of the EASL–CLIF Consortium
May 15, 2013·BMC Gastroenterology·Ahmed Al-ChalabiBernhard Kreymann
Oct 25, 2013·Critical Care Medicine·Vinod K AudimoolamGeorg Auzinger
Jul 16, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Shannan R TujiosUNKNOWN Acute Liver Failure Study Group
Feb 19, 2015·The New England Journal of Medicine·Marcelo B P AmatoRoy G Brower
Jul 15, 2015·Intensive Care Medicine·Eric A J HosteJohn A Kellum
Jul 24, 2015·Hepatology International·Shiv Kumar SarinUNKNOWN APASL ACLF Working Party
May 18, 2016·The New England Journal of Medicine·Stéphane GaudryUNKNOWN AKIKI Study Group
Jan 24, 2017·JAMA : the Journal of the American Medical Association·Eamon P RaithUNKNOWN Australian and New Zealand Intensive Care Society (ANZICS) Centre for Outcomes and Resource Evaluation (CORE)
Feb 18, 2017·Liver International : Official Journal of the International Association for the Study of the Liver·Katharina StauferValentin Fuhrmann
Apr 12, 2017·American Journal of Clinical Pathology·Michelle FoshatMarjan Afrouzian
Apr 19, 2017·Journal of Hepatology·UNKNOWN European Association for the Study of the Liver. Electronic address: easloffice@easloffice.euMauro Bernardi
Jul 1, 2017·Journal of Clinical and Translational Hepatology·Suman Lata NayakArchana Rastogi
Jul 6, 2017·Intensive Care Medicine Experimental·Ahmed Al-ChalabiBernhard Kreymann
Oct 4, 2017·JAMA : the Journal of the American Medical Association·V Marco RanieriJean-Louis Vincent
Feb 2, 2018·Intensive Care Medicine·Valentin FuhrmannJulia Wendon
Feb 17, 2018·Intensive Care Medicine·Jean-Louis VincentUNKNOWN SOAP investigators
Jan 12, 2019·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jan Hinrich BräsenIngmar Mederacke
Sep 20, 2019·Intensive Care Medicine Experimental·Aritz Perez Ruiz de GaribayBernhard Kreymann

❮ Previous
Next ❯

Software Mentioned

Stata
ADVOS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.